Arbutus Biopharma (ABUS) Shares Outstanding (Entity) (2010 - 2026)
Powered by 
Analysis
Arbutus Biopharma (ABUS) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Arbutus Biopharma | 1.01 Bn | 921.39 Mn | - | 197.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 197.63 Mn |
| Mar 31, 2026 | 196.95 Mn |
| Dec 31, 2025 | 192.53 Mn |
| Sep 30, 2025 | 191.95 Mn |
| Jun 30, 2025 | 191.64 Mn |
| Mar 31, 2025 | 191.48 Mn |
| Dec 31, 2024 | 189.96 Mn |
| Sep 30, 2024 | 189.44 Mn |
| Jun 30, 2024 | 188.74 Mn |
| Mar 31, 2024 | 180.19 Mn |
| Dec 31, 2023 | 169.87 Mn |
| Sep 30, 2023 | 167.70 Mn |
| Jun 30, 2023 | 166.92 Mn |
| Mar 31, 2023 | 165.13 Mn |
| Dec 31, 2022 | 157.46 Mn |
| Sep 30, 2022 | 152.71 Mn |
| Jun 30, 2022 | 148.79 Mn |
| Mar 31, 2022 | 148.73 Mn |
| Dec 31, 2021 | 106.24 Mn |
| Sep 30, 2021 | 110.26 Mn |